Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
Solomon HusainShivangi LohiaValentina PetkovTimothy BlackwellSamuel Swisher-McClureAviram MizrachiLuc G MorrisMarc A CohenRichard J WongBenjamin R RomanPublished in: Head & neck (2021)
Disparities exist among patients undergoing testing for HPV-associated OPSCC and adherence to guideline recommended HPV testing has been suboptimal. In addition, the HPV variable definition, especially as it relates to p16 positivity, and use in these two registries should be improved.